Efficient approaches toward the solid-phase synthesis of new heterocyclic azoniaspiro ring systems: Synthesis of tri- and tetrasubstituted 10-oxo-3,9-diaza-6-azoniaspiro[5.5]undecanes

Journal of Organic Chemistry

Volumn 70, Issue 23, 2005, Pages 9622-9625

  Nefzi, Adel ^a   Santos, Rodegar T ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACIDS; DERIVATIVES; NITROGEN; POLYPEPTIDES; POSITIVE IONS; SOLUTIONS; SYNTHESIS (CHEMICAL);

DIPEPTIDES; ISOCYANATES; SOLID-PHASE SYNTHESIS;

AROMATIC COMPOUNDS;

10 OXO 3,9 DIAZA 6 AZONIASPIRO[5.5]UNDECANE DERIVATIVE; ALIPHATIC AMINE; AZONIASPIRO COMPOUND; CARBONYL DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; DECANE; HETEROCYCLIC COMPOUND; ISOCYANIC ACID DERIVATIVE; NITROGEN; SPIRO COMPOUND; UNCLASSIFIED DRUG;

ACYLATION; ALKYLATION; ARTICLE; COMBINATORIAL CHEMISTRY; MOLECULAR MODEL; PEPTIDE ANALYSIS; REACTION ANALYSIS; SOLID PHASE SYNTHESIS; SUBSTITUTION REACTION;

ALKANES; AZA COMPOUNDS; HETEROCYCLIC COMPOUNDS; MODELS, CHEMICAL; MOLECULAR STRUCTURE;

EID: 27744589651     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0513921     Document Type: Article

References (42)

1. (a) Ramstrom, O.; Lehn, J.-M. Nat. Rev. Drug Discovery. 2002, 1, 26-36.
2. (b) Cano, M.; Balasubramanian, S. Drugs Future 2003, 28, 659.
3. (b) Flego, C. Chim. Oggi 2003, 21, 69.
4. (c) Belosludov, R. V.; Takami, S.; Kubo, M.; Miyamoto, A. Comb. Mater. Synth. 2003, 363.
5. (a) Southon, I. W.; Buckingham, D. J. In Dictionary of alkaloids; Cordell, G. A., Saxton, J. E. M., Eds.; Chapman and Hall: New York, 1989.
6. (a) Zacharis, H. M.; Trefonas, L. M. J. Am. Chem. Soc. 1971, 93, 2935.
7. (b) Cossar, B. C.; Reynolds, D. D. Res. Lab. Eastman Kodak Co. 1965, 2, 430.
8. (c) Baker, M. V.; Brown, D. H.; Skelton, B. W.; White, A. H. Aust. J. Chem. 2003, 53, 791.
9. (a) Takayanagi, M.; Sakurai, K.; Takehana, S.; Tashiro, K.; Yamamoto, H.; Sugiki, M.; Ichinose, H.; Ootani, K.; Hirashima, H.; Saitou, Y.; Matsushita, J. Patent WO 2004056813.
10. (b) Sagara, Y.; Uchiyama, M.; Naya, A.; Kimura, T.; Numazawa, T.; Fujikawa, T.; Otake, N.; Noguchi, Kazuhito. Patent WO 2001007406.
11. (c) Kajfez, F. Patent CH 586707.
12. (d) Kajfez, F.; Sunjic, V.; Sunjic, V. Patent ZA 7404892.
13. (e) Kajfez, F.; Sunjic, V.; Sunjic, V. Patent DE 2341110.
14. (f) Somers, T. C.; Bentley, G. A. Patent AU 248763, 1964.
15. (g) Anderson, E. L.; Casey, J. E.; Force, E. E.; Jensen, E. M.; Matz, R. S.; Rivard, D. E. J. Med. Chem. 1966, 9, 211.
16. (h) Somers, T. C.; Handley, G. J. J. Med. Chem. 1964, 7, 784.
17. (i) Lasslo, A.; Beasley, J. G.; Nelms, G. G; Epperson, G. J. J. Med. Chem. 1963, 6, 811.
18. (j) Thomas, J. J. Med. Phar. Chem. 1961, 3, 309.
19. (k) Schipper, E.; Chinery, E. J. Org. Chem. 1961, 26, 4135.
20. Millini, R.; Carluccio, L.; Frigerio, F.; Parker, W. O., Jr.; Bellussi, G. Microporous Mesoporous Mater. 1998, 24, 199.
21. (a) Herness, M. S.; Chen, Y. J. Memb. Biol. 2000, 173, 127.
22. (b) Chilmonczyk, Z.; Mazgajska, M.; Iskra-Jopa, J.; Chojnacka-Wojcik, E.; Tatarczynska, E.; Klodzinska, A.; Nowak, J. Z. J. Pha Phar. 2002, 54, 689.
23. (c) Ryckebusch, A.; Deprez-Poulain, R.; Maes, L.; Debreu-Fontaine, M.-A.; Mouray, E.; Grellier, P.; Sergheraert, C. J. Med. Chem. 2003, 46, 542.
24. (d) Pettit, G. R.; Melody, N.; Herald, D. L. J. Nat. Prod. 2004, 67, 322-327.
25. (e) Ryckmans, T.; Berton, O.; Grimee, R.; Kogej, T.; Lamberty, Y.; Pasau, P.; Talaga, P.; Genicot, C. Bio. Med. Chem. Lett. 2002, 12, 3195.
26. (f) Ibarra, M.; Hong, E.; Villalobos-Molina, R. J. Aut. Pharm. 2000, 20, 139.
27. (g) Askew, B. C.; McIntyre, C. J.; Hunt, C. A.; Claremon, D. A.; Baldwin, J. J.; Anderson, P. S.; Gould, R. J.; Lynch, R. J.; Chang, C. C.-T.; Cook, J. J.; Lynch, J. J.; Holahan, M. A.; Sitko, G. R.; Stranieri, M. T. Bio. Med. Chem. Lett. 1997, 7, 1531.
28. (h) Sugihara, H.; Fukushi, H.; Miyawaki, T.; Imai, Y.; Terashita, Z.-I.; Kawamura, M.; Fujisawa, Y.; Kita, S. J. Med. Chem. 1998, 41, 489.
29. (i) Batt, A. R.; Kendrick, D. A.; Mathews, E.; Rooker, D. P.; Ryder, H.; Semple, G.; Szelke, M. Bio. Med. Chem. Lett. 1994, 4, 867.
30. (j) Bergman, J. M.; Abrams, M. T.; Davide, J. P.; Greenberg, I. B.; Robinson, R. G.; Buser, C. A.; Huber, H. E.; Koblan, K. S.; Kohl, N. E.; Lobell, R. B.; Graham, S. L.; Hartman, G. D.; Williams, T. M.; Dinsmore, C. J. Bioorg. Med. Chem. Lett. 2001, 11, 1411.
31. (k) Nishida, H.; Miyazaki, Y.; Kitamura, Y.; Ohashi, M.; Matsusue, T.; Okamoto, A.; Hosaka, Y.; Ohnishi, S.; Mochiziku, H. Chem. Pharm. Bull. 2001, 49, 1237.
32. (l) Mazuzawa, K.; Mazaki, M.; Ohta, M. Chem. Pharm. Bull. 1966, 14, 194.
33. (a) Ostresh, J. M.; Schoner, C. C.; Hamashin, V. T.; Nefzi, A.; Meyer, J.-P.; Houghten, R. A. J. Org. Chem. 1998, 63, 8622-8623.
34. (b) Nefzi, A.; Ostresh, J. M.; Houghten, R. A. Tetrahedron 1999, 55, 335-344.
35. Better results were obtained with Dde.
36. Nefzi, A.; Giulianotti, M. A.; Houghten, R. A. Tetrahedron 2000, 56, 3319-3326.
37. Houghten, R. A. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 5131-5135.
38. Hall, D. G.; Laplante, C.; Manku, S.; Nagendran, J. J. Org. Chem. 1999, 64, 698.
39. Following separation of the two diastereomers, the absolute configuration of the ammonium was not determined.
40. Acetic anhydride and benzoyl chloride were used for the N-3 acylation.
41. (a) Nefzi, A.; Ostresh, J. M.; Houghten, R. A. Biopolymers (Peptide Sci.) 2001, 60, 212-219.
42. (b) Nefzi, A.; Ostresh, J. M.; Yu, Y.-P.; Houghten, R. A. J. Org. Chem. 2004, 69, 3603.